Tayrouz Haffar, Y. A., Ganßmann, B., Ding, R., Klingmann, A., Aderjan, R., Burhenne, J., . . . Mikus, G. (2001). Ritonavir increases loperamide plasma concentrations without evidence for P-glycoprotein involvement. Clinical pharmacology & therapeutics, 70(5), . https://doi.org/https://doi.org/10.1016/S0009-9236(01)35864-2
Chicago-Zitierstil (17. Ausg.)Tayrouz Haffar, Yorki Antoine, Beate Ganßmann, Reinhard Ding, Andrea Klingmann, Rolf Aderjan, Jürgen Burhenne, Walter E. Haefeli, und Gerd Mikus. "Ritonavir Increases Loperamide Plasma Concentrations Without Evidence for P-glycoprotein Involvement." Clinical Pharmacology & Therapeutics 70, no. 5 (2001). https://doi.org/https://doi.org/10.1016/S0009-9236(01)35864-2.
MLA-Zitierstil (9. Ausg.)Tayrouz Haffar, Yorki Antoine, et al. "Ritonavir Increases Loperamide Plasma Concentrations Without Evidence for P-glycoprotein Involvement." Clinical Pharmacology & Therapeutics, vol. 70, no. 5, 2001, https://doi.org/https://doi.org/10.1016/S0009-9236(01)35864-2.